Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000897486

Apexbio Technology LLC ANTI-EGFR PANITUMUMAB-5mg
SDP

Catalog No. 5000897486
Encompass_Preferred

Anti-ERBB1/EGFR/HER1 Antibody (Panitumumab) (CAS No 339177-26-3) is a monoclonal antibody used in oncology research targeting the epidermal growth factor receptor (EGFR) contributing to the inhibition of cancer cell proliferation Originating from recombinant DNA technology it binds specifically to EGFR blocking the activation of the receptor s intracellular kinase domain which is crucial in pathways such as MAPK and PI3K/AKT known for their role in cell growth and survival In vitro Panitumumab exhibits activity in the nanomolar range demonstrating its efficacy in inhibiting tumor growth It is typically applied in cell line studies such as A431 and HER1/EGFR-expressing transfected models and is employed in animal studies to evaluate anti-tumor activity in xenograft models Additionally it serves as a tool in drug screening for the development of EGFR-targeted therapies Experimental concentrations typically depend on the specific research design

Catalog No. 50-008-97486 Supplier Apexbio Technology LLC Supplier No. F14125
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Anti-ERBB1/EGFR/HER1 Antibody (Panitumumab) (CAS No 339177-26-3) is a monoclonal antibody used in oncology research targeting the epidermal growth factor receptor (EGFR) contributing to the inhibition of cancer cell proliferation Originating from recombinant DNA technology it binds specifically to EGFR blocking the activation of the receptor s intracellular kinase domain which is crucial in pathways such as MAPK and PI3K/AKT known for their role in cell growth and survival In vitro Panitumumab exhibits activity in the nanomolar range demonstrating its efficacy in inhibiting tumor growth It is typically applied in cell line studies such as A431 and HER1/EGFR-expressing transfected models and is employed in animal studies to evaluate anti-tumor activity in xenograft models Additionally it serves as a tool in drug screening for the development of EGFR-targeted therapies Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.